T2S Group Holding Moves Forward with Major Development Milestone

T2S Group Holding, a Moroccan company specializing in medical technologies, has reached a significant milestone in its development. On July 6, 2026, the group obtained approval from the Moroccan Capital Market Authority (AMMC) for its listing on the Casablanca Stock Exchange.

The operation, authorized under reference VI/EM/021/2026, has a total value of approximately 1.1 billion dirhams and aims to support the group’s growth in Morocco and across African markets.

A Fundraising and Share Sale

The public offering is based on two complementary components.

The first involves a public capital increase totaling 349.99 million dirhams, including the issuance premium.

The second consists of the sale of existing shares valued at 749.99 million dirhams, thus broadening the company’s shareholder base.

The subscription price has been set at 223 dirhams per share. The subscription period will take place from July 13 to July 17, 2026, until 3:30 PM, through participating banks and brokerage firms.

A Leading Player in Medical Technologies

Founded in 1992 by Abderraouf Sordo, a doctor in radiological physics, T2S Group Holding has established itself as a major player in the MedTech sector in Morocco.

The group provides healthcare facilities with equipment and solutions covering medical imaging, radiation therapy, analytical laboratories, medical devices, hospital digital systems, and maintenance services.

Its activities are based on two main pillars: the distribution and integration of high-tech medical equipment, and the production and research in the field of radiopharmacy.

An Innovation-Focused Strategy

Through its subsidiary, Cyclopharma, T2S Group produces radiopharmaceutical tracers for positron emission tomography (PET) examinations using a cyclotron facility located in Casablanca.

A second facility is already scheduled for Fès in 2028, aiming to double production capacity and better meet the needs of the northern and eastern regions.

The group is also developing digital solutions for healthcare institutions. For instance, its subsidiary Binarios designs AI-based tools to assist radiologists in analyzing and interpreting medical images.

A Presence in Africa and Growth Ambitions

T2S Group currently operates across several strategic segments, including radiology, oncology, operating rooms, hospital care, medical devices, radiopharmacy, hospital information systems, and after-sales service.

The group collaborates with over 40 international industrial partners, including GE Healthcare, BioMérieux, Accuray, and Boston Scientific, marketing more than 8,000 product references.

With 418 employees, a digitized logistics warehouse of 3,000 m², and a presence in over 20 African countries, T2S Group aims to strengthen its regional development.

The funds raised will be used to consolidate existing activities, launch new technological solutions, accelerate expansion in Africa, and pursue potential strategic acquisitions.

This operation is led by CFG Finance, which acts as the financial advisor and global coordinator for this stock market introduction.